SEC Form 4 · accession 0001209191-16-106542
INVACARE CORP · IVC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James L Jones
Director
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000742112
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1,F2 | Mar 3, 2016 | A | 5,678 | $0.00 | A | 27,627 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4,F3 | — | holding | — | — | — | — | — | Common Shares | 6,343 | 6,343 | D |
Explanation of responses
- F1Restricted stock units granted pursuant to the Invacare Corporation 2013 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These restricted stock units vest in full on May 15, 2017.
- F2Includes an aggregate of 9,932 restricted stock units issued pursuant to the Invacare Corporation 2013 Equity Compensation Plan.
- F3No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
- F4The reporting person holds previously reported options to buy 6,343 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between December 1, 2010 and December 22, 2010, at exercise prices between $22.7025 to $27.82 per share, will expire between December 31, 2016 and December 1, 2020, and became exercisable between September 30, 2011 and January 1, 2016.